<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="10071">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02105805</url>
  </required_header>
  <id_info>
    <org_study_id>GEN-01-clinnutr</org_study_id>
    <nct_id>NCT02105805</nct_id>
  </id_info>
  <brief_title>Weight Loss as Treatment in Heart Disease</brief_title>
  <official_title>Intentional Weight Loss as Treatment in Obese Patients With Ischaemic Heart Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Copenhagen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital, Gentofte, Copenhagen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Copenhagen</source>
  <oversight_info>
    <authority>Denmark: The Regional Committee on Biomedical Research Ethics</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      30 obese moderate-to-severe heart failure patients will be randomized to intervention or
      control in groups of 5-10 subjects.

      All will receive dietetic advice according to randomization and according to the European
      Heart Association.

      Intervention subjects will initiate with 8 weeks low energy diet, 800-1000 kcal/d by formula
      diet and subsequent four weeks reintroduction to regular foods supplying 1200 kcal/d
      substituting two daily meals with formula meal replacement.

      Control subjects are advised to follow the Nordic Nutrition Recommendations.

      Patients will be monitored by blood sampling and assessed by change in physical performance.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2010</start_date>
  <completion_date type="Actual">August 2011</completion_date>
  <primary_completion_date type="Actual">August 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Change in six minute walk test from baseline to week 16 (end of study)</measure>
    <time_frame>weeks 0 and 16</time_frame>
    <safety_issue>No</safety_issue>
    <description>Performance measure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in lipid status from baseline to week 16 (end of study).</measure>
    <time_frame>weeks 0,1,2,4,6,8,10,12,14,16</time_frame>
    <safety_issue>No</safety_issue>
    <description>Blood sample and analyses for lipids</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>low energy diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>low energy diet treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nordic recommendation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Nordic recommendation, no restrictions on energy</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Dietetic group sessions</intervention_name>
    <description>Group sessions to improve dietary adherence</description>
    <arm_group_label>low energy diet</arm_group_label>
    <arm_group_label>Nordic recommendation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  bmi &gt;30

          -  heart failure, moderate to severe, new york heart association II og III

          -  stable disease

          -  age &gt;18 years

          -  out-patients

          -  perform a six minutes walk test

          -  given consent

        Exclusion Criteria:

          -  unstable disease

          -  insulin treated diabetes

          -  pregnancy or lactating

          -  unstable weight past 6 months (+- 10 kg)

          -  planned procedures in the time of intervention
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 2, 2014</lastchanged_date>
  <firstreceived_date>March 28, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Copenhagen</investigator_affiliation>
    <investigator_full_name>Arne Astrup</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>intention weight loss</keyword>
  <keyword>heart failure</keyword>
  <keyword>6-minute walk test</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Weight Loss</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
